Literature DB >> 32258699

Analysis of combined impact of doxorubicin and menadione on human leukaemia Jurkat T cells: PS064.

Alexandru Ionut Duta1, Ioana Teodora Tofolean1, Ramona Madalina Babes1, Constanta Ganea1, Irina Baran1.   

Abstract

Entities:  

Year:  2017        PMID： 32258699      PMCID： PMC6806877          DOI： 10.1016/j.pbj.2017.07.087

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN： 2444-8664


× No keyword cloud information.
  3 in total

1.  Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells.

Authors:  Irina Baran; Diana Ionescu; Alexandru Filippi; Maria Magdalena Mocanu; Adrian Iftime; Ramona Babes; Ioana Teodora Tofolean; Ruxandra Irimia; Alexandru Goicea; Valentin Popescu; Alexandru Dimancea; Andrei Neagu; Constanta Ganea
Journal:  Leuk Res       Date:  2014-05-04       Impact factor: 3.156

2.  Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells.

Authors:  Ioana Teodora Tofolean; Constanta Ganea; Diana Ionescu; Alexandru Filippi; Alexandru Garaiman; Alexandru Goicea; Mihnea-Alexandru Gaman; Alexandru Dimancea; Irina Baran
Journal:  Pharmacol Res       Date:  2015-12-11       Impact factor: 7.658

3.  Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells.

Authors:  Irina Baran; Constanta Ganea; Agata Scordino; Francesco Musumeci; Vincenza Barresi; Salvatore Tudisco; Simona Privitera; Rosaria Grasso; Daniele F Condorelli; Ioan Ursu; Virgil Baran; Eva Katona; Maria-Magdalena Mocanu; Marisa Gulino; Raluca Ungureanu; Mihaela Surcel; Cornel Ursaciuc
Journal:  Cell Biochem Biophys       Date:  2010-12       Impact factor: 2.194
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.